BSE · PHRMASI.BO
Phaarmasia Limited
₹89.00₹0.00 (0.0%)
Phaarmasia Limited’s quoted price sits in the upper half of its reported 52-week range, 32.45% below the high.
Loading market information…
BSE · GLHRL.BO · INR
Stock price
Quote as of Oct 30, 2026, 07:03 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Global Longlife Hospital and R’s quoted price sits in the lower half of its reported 52-week range, 50.31% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Global Longlife Hospital & Research Ltd. operates as a comprehensive tertiary healthcare provider, offering a wide array of specialized medical services. The institution facilitates medical professionals by providing the essential environment and resources needed for patient treatment. Its clinical departments include, but are not limited to, acute care and emergency services, immunology and allergy, anesthesiology, bariatric procedures, burn treatment, cancer care, cardiology and vascular surgery, intensive critical care, advanced dental work and implants, as well as diabetes and endocrinology management. The company was established on January 20, 2012, and is headquartered in Ahmedabad, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:20 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹89.00₹0.00 (0.0%)
Phaarmasia Limited’s quoted price sits in the upper half of its reported 52-week range, 32.45% below the high.
₹18.40+₹0.27 (+1.49%)
Panjon Ltd.’s quoted price sits in the lower half of its reported 52-week range, 38.67% below the high.
₹45.00₹0.00 (0.0%)
KK Shah Hospitals Limited’s quoted price sits in the upper half of its reported 52-week range, 13.29% below the high.
₹18.80₹0.00 (0.0%)
Adeshwar Meditex Limited’s quoted price sits in the upper half of its reported 52-week range, 10.48% below the high.
₹12.90+₹0.54 (+4.37%)
Tejnaksh Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 30.65% below the high.
₹73.30-₹0.50 (-0.68%)
Ishita Drugs and Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 19.32% below the high.
₹25.00-₹1.18 (-4.51%)
Zenlabs Ethica Limited’s quoted price sits in the lower half of its reported 52-week range, 37.48% below the high.
₹2.40-₹0.02 (-0.83%)
Transgene Biotek Limited’s quoted price sits in the lower half of its reported 52-week range, 42.72% below the high.
